Leonard Goldberg, MD
MOHS-Micrographic Surgery · Bellaire, TXNPI 1023001708
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,484 of the $3,676 with a category attached, or 67.6%. LEO Pharma AS accounts for 67.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $2,544 and has fallen 91.2% since, to $224 in 2025.
Across 47 payments — averaging $78.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma AS$2K
- Sun Pharmaceutical Industries Inc.$291
- Genentech USA, Inc.$286
- Regeneron Healthcare Solutions, Inc.$141
- Sanofi$131
- Biofrontera Inc.$91
- plus $252 from 8 others
What the payments were for
- Consulting fees$2,48468%
- Food & beverage$1,09330%
- Education$993%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma AS | 1 | $2,484 |
| Sun Pharmaceutical Industries Inc. | 5 | $291 |
| Genentech USA, Inc. | 14 | $286 |
| Regeneron Healthcare Solutions, Inc. | 3 | $141 |
| Sanofi | 6 | $131 |
| Biofrontera Inc. | 5 | $91 |
| AbbVie | 4 | $67 |
| Springworks Therapeutics, Inc. | 2 | $46 |
| Revance Therapeutics, Inc. | 2 | $41 |
| UCB, Inc. | 1 | $37 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $12 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Winlevi$118
- ABSORICA LD$118
How this compares
$3,676 in reported general payments places this provider in the 65th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErivedgeVismodegib | 12 | $190,215 |
| Cephalexin | 18 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Erivedge | $286 | $190,21512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 109 mohs-micrographic surgery providers in Texas.
Other mohs-micrographic surgery in Bellaire
- Suneel ChilukuriBellaire$288K
- Kayla McNieceBellaire$13K
- Jeffrey BubleyBellaire$4K
- Aaron FarbergRockwall$1.5M
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.